banner

Disclosure of grants to patient organizations has been mandatory in Europe since March 2009. However, in Europe, the Middle East and Africa, Merck voluntarily began disclosing financial support to patient organizations in 2008, and in Canada in 2009.

In October 2009, Merck in Europe, the Middle East, Africa and Canada also began to disclose grants to other third-party organizations such as medical societies and scientific organizations. The information disclosed includes the organization, the amounts received, the dates of payment and the projects for which the money was used. Disclosures include all donations and charitable contributions, grants, and membership fees to professional societies or other medical or scientific organizations. Merck was also a member of the working group to develop the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code of Practice on Relationships between the Pharmaceutical Industry and Patient Organisations, which became effective on July 1, 2008.

Merck updates grants to medical, scientific and patient organizations annually for ex-U.S. jurisdictions.

DISCLOSURES OUTSIDE THE UNITED STATES


  • Copyright © 2009-2011 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.
TRUSTe - Click to Verify    This Web This Web Accessibility icon serves as a link to download eSSENTIAL Accessibility assistive technology software for individuals with physical disabilities. It is being featured as part of a Disability Community Involvement initiative that reflects our commitment to Diversity, Inclusion,Corporate Citizenship and Social Responsibility.